<DOC>
	<DOCNO>NCT01727817</DOCNO>
	<brief_summary>An unblinded , randomize , cross-over design patient participate two 40-hour outpatient admission : ( ) Experimental involve automate Control Range ( CTR ) ( b ) Control use Continuous Glucose Monitor ( CGM ) - augment insulin pump treatment outside hospital base clinical research center .</brief_summary>
	<brief_title>Early Feasibility Study 2 Outpatient Control-to-Range - Testing System Efficacy ( Italy )</brief_title>
	<detailed_description>The principal goal validate smart phone-based control-to-range ( CTR ) system ambulatory use estimate effect CTR vs. sensor-augmented pump therapy , thereby provide justification large home-based trial CTR .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 1</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<criteria>1 . ≥21 &lt; 65 year old . 2 . Clinical diagnosis type 1 diabetes mellitus . For individual enrol least one criterion list must meet . Criteria document hyperglycemia ( least 1 must meet ) : i. Fasting glucose ≥126 mg/dL confirm ii . Twohour Oral Glucose Tolerance Test ( OGTT ) glucose ≥200 mg/dL confirm iii . HbA1c ≥6.5 % document confirmed iv . Random glucose ≥200 mg/dL symptom v. No data diagnosis available participant convince history hyperglycemia consistent diabetes Criteria require insulin diagnosis ( 1 must meet ) : . Participant required insulin diagnosis continually thereafter ii . Participant start insulin diagnosis upon investigator review likely need insulin ( significant hyperglycemia respond oral agent ) require insulin eventually use continually iii . Participant start insulin diagnosis continue hyperglycemic , positive islet cell antibody consistent latent autoimmune diabetes adult ( LADA ) require insulin eventually use continually 3 . Use insulin pump treat his/her diabetes least 1 year . 4 . Familiarity bolus calculator current insulin pump predefined parameter carbohydrate ( CHO ) ratio , insulin sensitivity factor ( ISF ) , target glucose active insulin . 5 . HbA1c &lt; 9 % measure DCA2000 equivalent device . 6 . Not currently know pregnant , breast feeding , intend become pregnant ( female ) . 7 . Demonstration proper mental status cognition study . 8 . Willingness avoid consumption acetaminophencontaining product study intervention involve CGM use . 9 . If antihypertensive , thyroid , antidepressant lipid lower medication , stability medication least 2 month prior enrollment study . 1 . Severe hypoglycemia result seizure , loss consciousness , diabetic ketoacidosis within 12 month prior enrollment . 2 . Pregnancy ; breast feeding , intention become pregnant . 3 . Uncontrolled arterial hypertension ( Resting diastolic blood pressure &gt; 90 mmHg and/or systolic blood pressure &gt; 160 mmHg ) . 4 . Conditions may increase risk associate possible hypoglycemia , active cardiac disorder/arrhythmia , uncontrolled coronary artery disease previous year ( e.g . history myocardial infarction , acute coronary syndrome , therapeutic coronary intervention , coronary bypass stenting procedure , stable unstable angina , episode chest pain cardiac etiology document EKG change , positive stress test catheterization coronary blockage &gt; 50 % ) , congestive heart failure , history cerebrovascular event , seizure disorder , syncope , adrenal insufficiency , neurologic disease atrial fibrillation . 5 . Selfreported hypoglycemia unawareness . 6 . History systemic deep tissue infection methicillinresistant staph aureus Candida albicans . 7 . Use device may pose electromagnetic compatibility issue and/or radiofrequency interference CGM ( implantable cardioverterdefibrillator , electronic pacemaker , neurostimulator , intrathecal pump , cochlear implant ) . 8 . Anticoagulant therapy aspirin . 9 . Oral steroid . 10 . Medical condition require use acetaminophencontaining medication withheld study admission . 11 . Psychiatric disorder would interfere study task ( e.g . inpatient psychiatric treatment within 6 month prior enrollment ) . 12 . Mental incapacity , unwillingness language barrier preclude adequate understanding cooperation . 13 . Known current recent alcohol drug abuse . 14 . Medical condition would make operating CGM , DiAs cell phone insulin pump difficult ( e.g . blindness , severe arthritis , immobility ) . 15 . Any skin condition prevents sensor pump placement abdomen arm ( e.g . bad sunburn , preexist dermatitis , intertrigo , psoriasis , extensive scarring , cellulitis ) . 16 . In adherence One Touch Ultra 2 User Guide , subject hematocrit level less 30 % 55 % exclude . 17 . Impaired hepatic function measure alanine aminotransferase aspartate aminotransferase ≥three time upper reference limit . 18 . Impaired renal function measure creatinine &gt; 1.2 time upper limit normal . 19 . Uncontrolled microvascular ( diabetic ) complication , current proliferative diabetic retinopathy macular edema , know diabetic nephropathy ( microalbuminuria normal creatinine ) neuropathy require treatment . 20 . Active gastroparesis require current medical therapy . 21 . If antihypertensive , thyroid , antidepressant lipid lower medication , lack stability medication past 2 month prior enrollment study . 22 . Uncontrolled thyroid disease . 23 . Known bleed diathesis dyscrasia . 24 . Known allergy medical adhesive , component insulin pump insertion set continuous glucose monitor sensor . 25 . Active enrollment another clinical trial . 26 . Use antidiabetic agent continuous subcutaneous insulin infusion ( CSII ) include longacting insulin , intermediateacting insulin , metformin , sulfonylurea , meglitinides , thiazolidinediones , DPPIV inhibitor , glucagonlike peptide 1 agonist , alphaglucosidase inhibitor 27 . Subjects basal rate less 0.01U/hr .</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>64 Years</maximum_age>
	<verification_date>September 2014</verification_date>
	<keyword>Diabetes Mellitus , Type 1</keyword>
	<keyword>Continuous Glucose Monitor</keyword>
	<keyword>Artificial Pancreas</keyword>
	<keyword>Insulin Pump</keyword>
	<keyword>Closed Loop</keyword>
	<keyword>Open Loop</keyword>
	<keyword>Diabetes Assistant</keyword>
	<keyword>DiAs</keyword>
	<keyword>Cell Phone</keyword>
</DOC>